AMR activities and resources

2024


World AMR Awareness Week 2024 Webinar Series


Part 1: Epidemiology and Burden of Antimicrobial Resistance

Understanding the epidemiology and burden of antimicrobial resistance (AMR) is crucial for formulating effective public health strategies. This session will delve into the trends, regional variations and future projections of AMR – highlighting the importance of comprehensive data and targeted interventions.

28 October 2024, 17:00 - 18:00 CET

Moderators: Anna Both, Christian Kraef

  • AMR Time Trend and Future Health Scenarios of AMR Burden
    Mohsen Naghavi (University of Washington and Institute for Health Metrics and Evaluation, United States)
  • Regional Insights and Data Needs in AMR Burden Estimation
    Gisela Robles Aguilar (Oxford University, United Kingdom)

Watch the Replay


Part 2: Diagnostic Approaches and AMR Surveillance

Accurate and timely diagnosis is a cornerstone in the fight against AMR. This session will explore the challenges and innovations in diagnostic tools, especially in resource-limited settings, but also the importance of surveillance. It will also address global initiatives aimed at reducing diagnostic inequalities to improve AMR management worldwide.

6 November 2024, 17:00 - 18:00 CET

Moderators: Sara Tomczyk, Claudio Neidhöfer

  • Surveillance of Antimicrobial Resistance in the ECOWAS Region: Establishing the Foundation for Essential Interventions and Tackling Disparities in Diagnostics
    Ahmed Aboushady (Harvard Medical School, Boston, United States)
  • Resistance Surveillance and the Diversity of European Techniques
    Iva Butić (University of Zagreb, Croatia)

Registration to open soon!

Register here


Part 3: Antibiotics Development / AWARE

The development of new antibiotics and the optimisation of existing treatments are vital to counter the growing threat of AMR. This session will cover the latest strategies in antibiotic development, the challenges faced in different phases of drug development, and the efforts to improve diagnosis and treatment of antibiotic-resistant infections.

13 November 2024, 15:30 - 16:30 CET

Moderators: Tomislav Mestrovic, Giorgia Caruana

  • The Rise of Bacterial G-Quadruplexes in Current Antimicrobial Discovery
    Mattia Mori (University of Siena, Italy; Chair of the European Network for diagnosis and treatment of antibiotic-resistant bacterial infections – EURESTOP)
  • Comprehensive Phases of Antimicrobial Drug Development: From Discovery to Market
    Stephen Hawser (IHMA Europe Sàrl, Switzerland)

Register here


Part 4: Global Strategy

This session will be in collaboration with the International Society for Infectious Diseases (ISID)

Global collaboration and policy-making are essential to effectively combat AMR. This session will discuss the strategic directions from the policy-makers, the specific needs of low- and lower-middle-income countries (LMICs), as well as the potential role of vaccines in reducing AMR. The focus will be on actionable policies and collaborative efforts to address this global health challenge.

20 November 2024, 17:00 - 18:30 CET

Moderators: Holger Rohde, Nicholas Power

  • Global and Regional AMR Policy in a Current Landscape: Strategic Directions and The Opportunities for Implementation
    Jameela Mohammed Al-Salman (Chair of the WHO Strategic Technical Advisory Group on AMR / Arabian Gulf University, Bahrain)
  • Assessing the needs of implementing AMR policies in LMICs
    Sujith J Chandy(Executive Director, ICARS, Denmark)
  • Equity Perspectives of AMR Policy and Practice
    Connie Walyaro (ISID / Talk AB[M]R / WHO Expert Working Group on Equity and AMR, Kenya)

Register here


2023


World AMR Awareness Week 2023 – Day 1: evolutionary perspective on AMR emergence and control

Moderators: Holger Rohde, Giorgia Caruana

  • Lessons from environmental microbiology on the evolution of AMR
    Joakim Larsson, Sweden
  • Putting evolution into context: Role of human gut microbiota in AMR spread
    Willem van Schaik, United Kingdom
  • It’s all out there!? Mining for new approaches to combat AMR: Anti-resistance strategies, phages, and predators
    Paul Turner, United States

Watch the replay here


World AMR Awareness Week 2023 – Day 2: controlling the emergence of AMR: Is technology the saviour?

Moderators: Anna Both, Claudio Neidhöfer

  • Faster, broader, more accurate: Prospects of next generation microbiology for AMR control
    Adrian Egli, Switzerland
  • Staying one step ahead: How artificial intelligence can be a game changer in AMR control
    Roy Kishony, Israel
  • The fast car is not enough: Integrative approaches to AMR control
    Bojana Beovic, Slovenia

Watch the replay here

Joint AMR and Emerging Infection Subcommittee statement on hypervirulent Klebsiella pneumoniae

There is a concerning recent emergence of a hypervirulent Klebsiella pneumoniae exhibiting extensive or panresistant phenotype through acquisition of carbapenemase-encoding elements. Between the two ECDC risk assessments in March 2021 and February 2024 the number of EU/EEA countries reporting cases increased from 4 to 10, with the total number of reported cases increasing from 12 to 143. Despite control efforts, there is now evidence of sustained spread of a specific lineage of hypervirulent carbapenemase-producing K. pneumoniae, i.e. ST23-K1, in one European country (Ireland) as well as potential within-country transmission in three other European countries (France, Latvia, and Lithuania) although epidemiological data to confirm this were missing.  

Links


New report from the GLG on AMR

A new report from the Global Leaders Group (GLG) on AMR outlines 10 policy recommendations for consideration at the UN General Assembly High-level Meeting on AMR in September 2024.

Download